Fibrinogen Derived Coagulation Inhibitors in Obstetric Cases of Acute Fibrinolysis

Ireneusz Roszkowski; Marta Niewiarowska; Jadwiga Bar-Pratkowska

doi:10.1055/s-0038-1656284

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1965; 13(01): 025-034
DOI: 10.1055/s-0038-1656284

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Fibrinogen Derived Coagulation Inhibitors in Obstetric Cases of Acute Fibrinolysis

Ireneusz Roszkowski

¹Second Obstetrical Clinical Department, Medical School, Warsaw, Poland

,

Marta Niewiarowska

¹Second Obstetrical Clinical Department, Medical School, Warsaw, Poland

,

Jadwiga Bar-Pratkowska

¹Second Obstetrical Clinical Department, Medical School, Warsaw, Poland

› Author Affiliations

Abstract

Summary

The authors described the presence of fibrinogen derived coagulation inhibitors antithrombin VI and inhibitor of thromboplastin generation (I.G.T)in blood plasma of two patients with placenta praevia and ablatio placentae praecox. Antithrombin VI-like inhibitor has been present in pleural fluid of one patient.

The physiological and pathological significance of these inhibitors is discussed.

Full Text

References

References
1 Alaquie D, Soulier J. P. Action des inzymes protéolitiques sur le sang total in vitro. Sem. Hop. Paris 32: 355 1956;
2 Bar-Pratkowska J, Niewiarowska M. O aktywacji plazminogenu w przypadku przedwczes-nego odklejenialozyska. Poi. Tyg. lek. 13: 1908 1958;
3 Beller F. K, Glas P, Poemer H. Fibrinogenolysis as cause of obstetric hemorrhage. Amer. J. Obstet. Gynec. 82: 620 1961;
4 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv for Kemi 10: 415 1956;
5 Deutsch E, Fischer M. Die Wirkung intravenös applizierter Streptokinase auf Fibrinolyse und Blutgerinnung. Thrombos. Diathes. haemorrh. (Stuttg.) 4: 482 1960;
6 Duckert F, Flückiger P, Isenschmidt H, Matter M, Vogel-Meng J. A modification of they thromboplastin generation test. Acta haemat. (Basel) 12: 197 1954;
7 Halse T. Fibrinolyse. Cantor Ed. Freiburg 1948
8 Hatton R. L. Coagulation defects in patients with abruptio placentae. Amer. J. Obstet. Gynec. 82: 177 1961;
9 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor. Acta haemat. (Basel) 6: 1 1951;
9a Kopec M, Kowalski E, Stachurska J. Studies on paracoagulation. Bole of antithrombin VI. Thrombos. Diathes. haemorrh. (Stuttg.) 5: 285 1961;
10 Kowalski E. Fibrinogen derived inhibitors of blood coagulation. Thrombos. Diathes. haemorrh. (Stuttg.): Suppl. 4, 1960, p. 211
11 Kowarzyk H, Buluk K. Postejpy badán nad krzepnieciem krwi. Postçpy Hig. Med. dósw. 2: 1 1950;
12 Lewis J. H, Ferguson J. H. Partial purification of human prothrombin and proconvertin; their characteristics and interaction. J. clin. Invest. 32: 915 1953;
13 Lipinski B, Kowalski E. Isolation and purification of a glycoprotein fraction from fibrinogen digested by plasmin. Bull. Acad. poi. Sci. Cl. 2 9: 251 1961;
13a Loeliger E. A, Esch B. C. Ch. ter Haar Romeny-Wächter and H. L. Booij. Factor VII: Its turnover rate and its possible role in thrombogenesis. Thrombos. Diathes. haemorrh. (Stuttg.) 4: 196 1960;
14 Niewiarowska M, Wegrzynowicz Z. Influence of dicumarol derivatives on plasma fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 3: 279 1959;
15 Niewiarowski S. L’adsorbtion des facteurs du système fibrinolytique par la bentonite. Path, et Biol. 7: 2557 1959;
16 Niewiarowski S, Kowalski E. Antithrombin formation during proteolysis of fibrinogen. Sixth Congress of Europ. Soc. of Haemat. p. 158. Copenhagen 1957
17 Niewiarowski S, Latallo Z. Influence of plasmin on the first coagulation stage. Bull. Acad, poi. Sci. Cl. 27: 219 1957;
18 Niewiarowski S, Latallo Z, Stachurska J. L’apparition d’un inhibiteur de la thrombo-plastinoformation au cours de la protéolyse du fibrinogène. Revue Hémat. 14: 118 1959;
19 Niewiarowski S, Kowalski E, Stachurska J. Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system. Acta biochim. pol. 6: 43 1959;
20 Norman P. S. Effect of urea and methylamine on plasmin. Proc. Soc. exp. Biol. (N.Y.) 96: 709 1957;
21 Phillips L. L. Etiology of afibrinogenemia, fibrinogenolytic and fibrinolytic phenomena. Ann. N. Y. Acad. Sci. 75: 676 1959;
22 Quick A. J. Hemorrhagic Diseases. Lee and Febiger; Philadelphia: 1957
23 Schneider G. L. Mechanism of production of acute fibrinogen deficiencies. Progr. Haemat. 1: 202 1956;
24 Sharp A. A, Howie B, Biggs R, Methuen D. T. Defibrination syndrome in pregnancy. Lancet 71: 1309 1958;
25 Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and fibrinolytic therapy in man. Physiol. Rev. 39: 343 1959;
26 Sherry S, Fletcher A. P, Alkjaersig N. Developments in fibrinolytic therapy for thromboembolic disease. Ann. intern. Med. 50: 560 1959;
27 Stefanini M. Mechanism of blood coagulation in normal and pathologie condition. Amer. J. Med. 14: 64 1953;
28 Triantaphyllopoulos D. G. Nature of the thrombin-inhibiting effect of incubated fibrinogen. Amer. J. Physiol. 197: 575 1959;
29 Triantaphyllopoulos D. G. Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation. Canad. J. Biochem. 38: 909 1960;
30 Wolf P. A modification for routine laboratory use of Stefanini’s method of estimating Factor V activity in human oxalated plasma. J. clin. Path. 6: 34 1953;
31 Zaman G. L. Fibrinolysis in the pleural cavity after pulmonary resection II Antithrombin activity of the pleural exudate after pulmonary resection (Significance of fibrinolysis for haemostasis). Thrombos. Diathes. haemorrh. (Stuttg.) 9: 211 1963;
32 Zywicka H, Kopec M, Batallo Z, Kowalski E. L’apparition d’un inhibiteur resembl antanti-thrombine VI chez une malade atteinte d’une diathese hemorrhagique au cours de lupus ery-themateux. Thrombos. Diathes. haemorrh. (Stuttg.) 6: 63 1961;